Volume 28, Issue 170 (3-2019)
J Mazandaran Univ Med Sci 2019, 28(170): 11-21 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Moghadam A, Noori-Zadeh A, Darabi S, Rajaei F, Abbaszadeh H, Ghasemi Hamidabadi H. Dopaminergic Neuroprotection with Ginkgolide in
6-Hydroxydopamine Rat Parkinson’s Disease Model
. J Mazandaran Univ Med Sci 2019; 28 (170) :11-21
URL: http://jmums.mazums.ac.ir/article-1-11726-en.html
URL: http://jmums.mazums.ac.ir/article-1-11726-en.html
Alireza Moghadam 
, Ali Noori-Zadeh , Shahram Darabi , Farzad Rajaei , Hojjat-allah Abbaszadeh , Hatef Ghasemi Hamidabadi
, Ali Noori-Zadeh , Shahram Darabi , Farzad Rajaei , Hojjat-allah Abbaszadeh , Hatef Ghasemi Hamidabadi
Abstract: (3626 Views)
Background and purpose: Parkinson's disease (PD) is a prevalent movement disorder in elderly with progressive motor complications due to antioxidant defense system deficiency and accumulation of degraded proteins in dopaminergic neurons of midbrain. Ginkgolide is biologically active terpenic lactones as a polyphenol, with potent antioxidant and anti-inflammatory properties. The present study aimed to evaluate the neuroprotective effects of Ginkgolide in 6-hydroxydopamine (6-OHDA) rat model of PD.
Materials and methods: Intrastriatal 6-OHDA-parkinson’s disease rat model was pretreated with Ginkgolide at 50 mg/kg/day for 4 weeks. Apomorphine-induced rotation test was applied to evaluate the neuroprotective effects of Ginkgolide. In addition, the antioxidant effects of Ginkgolide were assessed by analyzing the levels of thiobarbituric acid reactive substances (TBARS), Glutathione-S-transferase (GST), reactive oxygen species (ROS) homovanillic acid (HVA), and dopamine (DA).
Results: Ginkgolide pretreatment led to reduced nigral and striatal TBARS, and ROS and increased the levels of GST, HVA, and DA. Meanwhile, Ginkgolide attenuates apomorphine-induced rotational bias and reduced contra-lateral rotation in Ginkgolide treatment group.
Conclusion: These findings indicated the neuroprotective potential of Ginkgolide in 6- OHDA rat model of PD via amelioration of oxidative stress.
Materials and methods: Intrastriatal 6-OHDA-parkinson’s disease rat model was pretreated with Ginkgolide at 50 mg/kg/day for 4 weeks. Apomorphine-induced rotation test was applied to evaluate the neuroprotective effects of Ginkgolide. In addition, the antioxidant effects of Ginkgolide were assessed by analyzing the levels of thiobarbituric acid reactive substances (TBARS), Glutathione-S-transferase (GST), reactive oxygen species (ROS) homovanillic acid (HVA), and dopamine (DA).
Results: Ginkgolide pretreatment led to reduced nigral and striatal TBARS, and ROS and increased the levels of GST, HVA, and DA. Meanwhile, Ginkgolide attenuates apomorphine-induced rotational bias and reduced contra-lateral rotation in Ginkgolide treatment group.
Conclusion: These findings indicated the neuroprotective potential of Ginkgolide in 6- OHDA rat model of PD via amelioration of oxidative stress.
Type of Study: Research(Original) |
Subject:
Neurology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
